LCI-HEM-SPEC-001: Tissue Collection for Genetic Analysis of Acute Myelogenous Leukemia

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

6 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-11-30

Study Completion Date

2016-12-22

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to obtain high quality specimens for molecular studies for the identification and characterization of genetic mutations involved in the pathogenesis of familial myeloid malignancies. Specimens obtained will be de-identified, linked to basic clinical data, and sent to Washington University (Division of Oncology, St. Louis, MO) for molecular analyses. Some specimens sent to Washington University may also be used for quality control analyses.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Blood and Tumor Tissue Samples From Young Patients With Acute Myeloid Leukemia

NCT01139333

Leukemia

COMPLETED

Establishing a Tumor Bank in Families With Multiple Lymphoproliferative Malignancies

NCT00131014

Non-Hodgkin's Lymphoma Hodgkin's Disease Leukemia, Lymphocytic, Chronic +1 more

RECRUITING

Biomarker Changes in Samples From Young Patients With Acute Myeloid Leukemia

NCT01139931

Leukemia

COMPLETED

Role of Biomarkers in Disease Progression in Samples From Patients With Acute Myeloid Leukemia

NCT01500499

Leukemia

COMPLETED

Studying Gene Expression in Tissue Samples From Patients With Acute Myeloid Leukemia

NCT01057095

Leukemia

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a specimen collection study for patients receiving standard of care treatment for AML. Specimens collected will be 1) bone marrow biopsy and aspiration, 2) peripheral blood, 3) skin punch biopsy, and 4) oral rinse. Collection of these specimens will be at timepoints determined by the patient's standard of care and their physician Investigator.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Leukemia, Myelogenous, Acute

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patient

Specimen Collection

No interventions assigned to this group

Relative

Specimen Collection

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients must have a diagnosis of acute myelogenous leukemia.
* Family members of patients with acute myelogenous leukemia may be enrolled.
* Informed consent must be provided by the patient or his/her legal guardian in accord with the practices of Levine Cancer Institute and Atrium Health.